Abstract
Any inflammatory process is accompanied by the invasion of polymorphonuclear neutrophils (PMN) which emigrate from the vascular bed through the blood capillary walls into the surrounding tissue towards the site of inflammation (Fig. 1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
T. J. Williams and P. G. Hellewell, Endothelial cell biology. Adhesion molecules involved in the microvascular inflammatory response, Am. Rev. Respir. Dis. 146, 45–50 (1992)
M. P. Bevilacqua and R. M. Nelson, Selectins, J. Clin. Invest. 91, 379–387 (1993)
E. C. Butcher, Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity, Cell 67, 1033–1036(1991)
R. Pardi, L. Inverardi, and J. R. Bender, Regulatory mechanisms in leukocyte adhesion: flexible receptors for sophisticated travelers, Immunol. Today 13, 224 (1993)
T. M. Carlos and J. M. Harlan, Leukocyte-endothelial adhesion molecules, Blood 84, 2068–2101 (1994)
B. Bakowski and H. Tschesche, Migration of polymorphonuclear leukocytes through human amnion membrane–A scanning electron microscopic study Biol. Chem. Hoppe-Seyler 373, 529–546 (1992)
I. I. Singer, S. Scott, D. W. Kawda, D. M. Kazazis, Adhesomes: Specific granules containing receptors for laminin, C3bi/fibrinogen, fibrinectin, and vitronectin in human polymorphonuclear leucocytes and monocytes, J. Cell Biol. 109, 3169–3182 (1989)
R. Snyderman and R. J. Uhing, Phagocytic cells: stimulus-response coupling mechanisms, in: Inflammation: Basic Principles and Clinical Correlates, 309–332 ( J. I. Gallin, I. M. Goldstein, and R. Snyderman, eds.), Raven Press, New York (1988)
H. Tschesche. A. Schettler, H Thorn, B. Bakowski, V. Knäuper, H. Reinke, and B. M. Jockusch, Chemotaxis, proteinase secretion and activation of collagenase of PMN leucocytes in: Proteinases and Their Inhibitors - Recent Developments, Proceedings of the 8th Winter School, (E. Auerswald, H. Fritz, V. Turk, eds.) 31–36, KFA Jülich GmbH, (1989)
A. Schettler, H. Thorn, B. M. Jockusch, and H. Tschesche, Release of proteinases from stimulated polymorphonuclear leukocytes: Evidence for subclasses of the main granule types and their association with cytoskeletal components, Eur. J. Biochem. 197, 197–202 (1991)
D. G. Wright and J. I. Gallin, Secretory responses of human neutrophils: Exocytosis of specific (secondary) granules of human neutrophils during adherence in vitro and during exudation in vivo, J. Immunol. 123, 285–294 (1979)
M. C. M. Vissers, C. C. Winterbourn, and J. S. Hunt, Degradation of glomerular basement membrane by human neutrophils in vitro, Biochem. Biophy.s. Acta, 804, I54–160 (1984)
V.-J. Uitto, D. Schwartz, and A Veis, Degradation of basement-membrane collagen by neutral proteases from human leukocytes, Eur. J. Biochem. 105, 409–417 (1980)
R. A. D. Bunning, G. Murphy. S. Kumar, P. Phillips, and J. J. Reynolds, Metalloproteinase inhibitors from bovine cartilage and body fluids, Eur.1. Biochem. 139, 75–80 (1984)
Y. A. De Clerck, T.-D. Yean, B. J. Ratzkin, H. S. Lu, and K. E. Langley, Purification and characterization of two related but distinct metallo-proteinase inhibitors secreted by bovine aortic endothelial cells, J. Bio! Chem. 264, 17445–1 7453, (1989)
G. I. Goldberg, B. L. Manner, G. A. Grant, A. Z. Eisen, and S. Wilhelm, Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2, Proc. Vail. Acad. Sci. USA 86, 8207–8211 (1989)
W. G. Stetler-Stevenson, H. C. Krutzsch, and L. A. Liotta, Tissue Inhibitor of Metalloproteinase (TIMP-2), J. Biol. Chen. 264, 17374–17378 (1989)
E. J. Campbell and M. A. Campbell, Pericellular proteolysis by neutrophils in the presence of proteinase inhibitors: Effects of substrate opsonizatìon, J. Cell Biol. 106, 667–676 (1988)
A. F. Brown, Neutrophil granulocytes: Adhesion and locomotion on collagen substrata and in collagen matrices, J. Cell Sci. 58, 455. 467 (1982)
H. Tschesche, Human neutrophil collagenase in: Methods in Enzymology, 248, (A.J.Barrett, ed.), 431–449, Academic Press, San Diego (1995)
G. Murphy and T. Crabbe, Gelatinases A and B, Methods in Enzvmol. 248, 470–484 (1995)
H. Tschesche, C. Kopp, W. H. Hörl, and U. Hempelmann, Inhibition of degranulation of polymorphonuclear leukocytes by angiogenin and its tryptic fragment, J. Biol.Chem. 269, 30274–30280 (1994)
N. Balke, U. Holtkamp, W.H. Hörl, and H. Tschesche, Inhibition of degranulation of human polymorphonuclear leukocytes by complement factor D, FEBS Lett. 371, 300–302 (1995)
H. Tschesche, V. Knäuper, S. Krämer, J. Michaelis, R. Oberhoff, and H. Reinke, Latent collagenase and gelatinase from human neutrophils and their activation, in: MATRIX Supplement 1, 245–255 ( H. BirkedalHansen, Z. Werb, H. Welgus and H. Van Wart eds.), Gustav-Fischer Verlag, Stuttgart, New York, (1992)
G. Murphy, R. Ward, J. Gavrilovic, and S. Atkinson, Physiological mechanisms for metalloproteinase activation, in: MATRIX Supplement 1, 224–230 ( H. Birkedal-Hansen, Z. Werb, H. Welgus and H. Van Wart eds.), Gustav Fischer Verlag, Stuttgart, New York (1992)
H. Nagase, K. Suzuki, T. Morodomi, J. J. Enghild, and G. Salvesen, Activation Mechanisms of the precursors of matrix metalloproteinases 1,2 and 3, in: MATRIX Supplement 1, 237–244 ( H. Birkedal-Hansen, Z. Werb, H. Welgus and H. Van Wart eds.), Gustav Fischer Verlag, Stuttgart, New York (1992)
E. B. Springman, E. L. Angleton, H. Birkedal-Hansen, and H. E. van Wart, Biochemical basis for multiple modes of activation of human fibroblast collagenase, in: MATRIX Supplement 1, 76–77(H. Birkedal-Hansen, Z. Werb, H. Welgus and H. Van Wart eds.), Gustav Fischer Verlag, Stuttgart, New York (1992)
S. J. Weiss, G. Peppin, X. Ortiz, C. Ragsdale, and S. T. Test, Oxidative activation of latent collagenase by human neutrophils, Science 227, 747–749 (1985)
E. B. Springman, E. L. Angleton, H. Birkendal-Hansen, and H. E. Van Wart, Multiple modes of activation of latent human fibroblast collagenase: Evidence for a role of a Cys73 active-site zinc complex in latency and a “cysteine switch” mechanism for activation, Proc. Natl. Acad Sci. USA 87, 364–368 (1990)
W. Bode, P. Reinemer, R. Huber, T. Kleine, S. Schnierer, and H. Tschesche, The X-ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity, EMBO J. 6, 1263–1269 (1994)
P. Reinemer, F. Grams, R. Huber, T. Kleine, S. Schnierer, M. Pieper, H. Tschesche, and W. Bode, Structural implications for the role of the N-terminus in the “superactivation” of collagenases. A crystallographic study, FEBS Lett. 338, 227–233 (1994)
V. Knäuper, S. Krämer, H. Reinke, and H. Tschesche, Characterization and activation of procollagenase from human polymorphonuclear leucocytes–N-terminal sequence determination of the proenzyme and various proteolytically activated forms, Eur. J. Biochem. 189, 295–300 (1990)
J. M. Clark and T. E. Cawston,Fragments of human fibroblast collagenase purification and characterization, Biochem. J. 263, 201–206 (1989)
V. Knäuper, S. M. Wilhelm, P.K. Seperack, Y. A. DeClerck, K. E. Langley,A. Osthues, and H. Tschesche. Direct activation of human neutrophil procollagenase by recombinant stromelysin, Biochem. J. 295. 581–586(1993)
S. Schnierer, T. Kleine, T. Gote, A. Hillemann, V. Knäuper, and H. Tschesche, The recombinant catalytic domain of human neutrophil collagenase lacks type I collagen substrate specificity, Biochern. Bïaphrs. Res. Comm. 191, 319–326 (1993)
E. J. Miller, E. D. Harris, Jr., E. Chung. D. E. Finch, Jr., P. A. McCroskery, and W. T. Butler, Cleavage of type Il and HI colagens with mammalian collagenase: Site of cleavage and primary structure at the NH,-terminal portion of the smaller fragment released from both collagens, Biochemistry 15, 787 (1976)
A. J. Fosang, K. Last, P. J. Neame, G. Murphy, V. Knäuper, H. Tschessche, C. E. Hughes, B. Caterson, and T. E. Hardingam. Neutrophil collagenase (MMP-8) cleaves at the aggrecanase site E373–A374 in the inter-globular domain of cartilage aggrecan, Biochem. J. 304, 347–351 (1994)
V. Knäuper, H. Reinke and H. Tschesche,lnactivation of Human Plasma l-Proteinase Inhibitor by Human PMN Leucocyte Collagenase, FEBS Lett. 263, 355–357 (1990)
V. Knäuper, S. Triebel, H. Reinke and H. Tschesche,lnactivation of human plasma Cl-inhibitor by human PMN leucocyte matrix metalloproteinases, FEBS Lett. 290 99–102 !;1991)
O. Diekmann and H. Tschesche, Degradation of kinins, angiotensins and substance P by polymorphonuclear matrix metalloproteinases MMP 8 and MMP 9, Braz. J. Med. Biol. Res. 27, 1877–1883 (1994)
I. Walter, I. Wölker and W. Kuhn, Serum collagenase levels during pregnancy and parturition. R. Osmers, M. A. Pflanz, W. Rath, M. Szeverényi, V. Süwer, H. Tschesche, EurJ. Obstet. Gvnecol. Reprod. Biot 53, 55–57 (1994)
R. G. W. Osmers, B. C. Adelmann-Grill, W. Rath, H. W. Stuhlsatz, H. Tschesche, and W. Kuhn, Biochemical events in cervical ripening dilatation during pregnancy and parturition, J. Obstet. Gynaecol. 21, 185–194 (1996)
R. Osmers, H. Tschesche, J. Bläser, Th. Cunze, B. Lefhalm, and W. Kuhn, Bedeutung von I1–1 und II-8 während der Geburt, 110. Congress Norddeutsche Gesellschafi für Gynäkologie und Gehurtshiije,Abstract No. 89 142–143 (1995)
M. Takagi, Y. Konttinen, P. Kemppinen, T. Sorsa, H. Tschesche, J. Bläser. A. Suda, and S. Santavirta. Tissue inhibitor of metalloproteinase (TIMP)- 1 and collagenolytic and gelatinolytic potential in loose THR endoprostheses, J. Rheumatot. 22, 2285–2290, (1995)
T. Sorsa, Y.-L. Ding, T. Ingman, T. Salo, U. Westerlund, M. Haapasalo, H. Tschesche, and Y.T. Konttinen, Cellular source, activation and inhibition of dental plaque collagenase, J. Clin. Periodontol 22, 709 717 (1995)
H. Tschesche, B. Bakowski, A. Schettler, V. Knäuper, and H. Reinke, Leukodiapedesis, release of PMN leucocyte proteinases and activation of PMNL procollagenase, Biomed. Biochim. Acta 50, 755–761 (1991)
L. A. Liotta, U. P. Thorgeirsson, and S. Garbisa, Role of collagenases in tumor cell invasion. Cancer Metastasis Rev. 1, 277–288 (1982)
W. G. Stetler-Stevenson, Type IV collagenases in tumour invasion and metastasis, Rev. 9, 289–303 (1990)
H. Sato, T. Takino, Y. Okada, J. Cao, A. Shinagawa, E. Yamamoto, and M. Seiki, A matrix metalloproteinase expressed on the surface of invasive tumour cells, Nature 370, 61–65 (1994)
A. Y. Strongin, I. Collier, G. Bannikov, B. L. Marmer, G. A. Grant, and G I. Goldberg, Mechanism of cell surface activation of 72-kDa type IV collagenase, J. Biol. Chem. 270, 5331–5338 (1995)
H. Sato and M. Seiki, Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis, J. Biochem. 119, 209–215 (1996)
R. V. Ward, S. J. Atkinson, J. J. Reynolds, and G. Murphy, Cell surface-mediated activation of progelatinase A: Demonstration of the involvement of the C-terminal domain of progelatinase A in cell surface binding and activation of progelatinase A by primary fibroblasts, Biochem J. 304, 263–269 (1994)
H. Will, S. J. Atkinson, G. S. Butler, B. Smith, and G. Murphy, The soluble catalytic domain of membrane type I matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates äutoproteolytic activation, J. Biol. Chem. 271, 17119–17123 (1996)
A. Lichte, H. Kolkenbrock, and H. Tschesche, The recombinant catalytic domain of membrane-type matrix metalloproteinase-1 (MT-MMP) induces activation of progelatinase A and progelatinase A complexed with TIMP-2, FEBS Lett. 397, 277–282 (1996)
X. S. Puente, A. M. Pendäs, E. Llano, G. Velasco, and C. López-Otin, Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma, Cancer Research 56, 944–949 (1996)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Tschesche, H. (1997). Leukodiapedesis, Function, and Physiological Role of Leucocyte Matrix Metalloproteinases. In: Ansorge, S., Langner, J. (eds) Cellular Peptidases in Immune Functions and Diseases. Advances in Experimental Medicine and Biology, vol 421. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9613-1_38
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9613-1_38
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9615-5
Online ISBN: 978-1-4757-9613-1
eBook Packages: Springer Book Archive